Clinical Trials Browser

Metastatic Hormone Sensitive Prostate Cancer × Androgen Antagonists × Clear all

NCT04076059 2026-04-17

China ARCHES

Phase 3 Active not recruiting

180 enrolled 24 charts

Metastatic Hormone Sensitive Prostate Cancer